February 17, 2024

Good morning. Every Saturday, we publish the results of polls from feature stories that were published the past week. We also give a brief overview of the topics that were discussed.

🗳️ POLL RESULTS – Week 162
*Only subscribers can participate in polls.


Is CAR T-cell therapy the future of cancer treatment?

Daily | 12 February 2024

One cancer treatment of note is the Chimeric Antigen Receptor (CAR)-T cell therapy. The basic premise is genetically modifying a patient’s T-cells to recognise and attack cancer cells. It has been called a revolutionary new pillar in cancer treatment. Does it represent the long-term future? Read more on this here.

Does the Centre’s anti-UPA White Paper hold up?

Daily | 13 February 2024

The government is touting its economic credentials through a White Paper comparing the previous UPA government to itself. Spoiler alert – it states the current government is better for the country, and things weren’t so good under the UPA. Does this white paper, touting the NDA as the country’s saviour, hold up to scrutiny? We discuss it here.

Are southern states in India right in protesting lower tax devolution?

Daily | 14 February 2024

As election season gathers steam, the southern states have turned up the heat against the Centre. They feel that they’ve been getting a raw deal concerning financial devolution. While they allege mistreatment by the Centre, the latter doesn’t buy it. Do the states have a point, or is it just political grandstanding? We unpack this here.

Is the farmers’ ask for an MSP guarantee feasible?

Daily | 16 February 2024

Farmers are once again on the move to protest. This time, it’s for something they’ve asked for before – a legal guarantee for Minimum Support Price (MSP). While there’s already some version of an MSP, the next step is a legal guarantee. Will it be feasible? Find the debate here.